Literature DB >> 7847069

Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer beta-amyloid deposition.

H Yamaguchi1, K Ishiguro, S Sugihara, Y Nakazato, T Kawarabayashi, X Sun, S Hirai.   

Abstract

The localization of apolipoprotein E (ApoE) has been examined immunohistochemically in the autopsied brains of middle-aged and old-aged control subjects, with and without amyloid beta protein (A beta) deposits, and of Alzheimer's disease patients. Senile plaques were consistently labeled with ApoE antiserum even in the very early stage of senile plaque formation seen in the fifth decade. In the cerebellar molecular layer, small dots of ApoE immunoreactivity, which were prominent in the Alzheimer's disease subjects, were observed in addition to immunoreactivity in diffuse plaques. ApoE antisera labeled all of the extracellular neurofibrillary tangles (NFT), whereas only a small minority of extracellular NFT were positive for A beta. A punctate pattern of ApoE immunoreactivity was seen at the media of the meningeal vessels lacking amyloid, when senile plaques were present in the nearby cortex. In the early stage of amyloid angiopathy, the distribution of ApoE immunoreactivity was much more extensive than that of A beta positivity. These findings suggest that ApoE accumulates in the early stage of senile plaque formation and, furthermore, that ApoE accumulation precedes A beta deposition in extracellular NFT and amyloid angiopathy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7847069     DOI: 10.1007/bf00389492

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  42 in total

1.  Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA.

Authors:  J M Pasternack; C R Abraham; B J Van Dyke; H Potter; S G Younkin
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

2.  Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study.

Authors:  H Yamaguchi; T Yamazaki; C A Lemere; M P Frosch; D J Selkoe
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

3.  Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells.

Authors:  J Busciglio; D H Gabuzda; P Matsudaira; B A Yankner
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

4.  Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.

Authors:  T Wisniewski; A Golabek; E Matsubara; J Ghiso; B Frangione
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

5.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Authors:  W J Strittmatter; K H Weisgraber; D Y Huang; L M Dong; G S Salvesen; M Pericak-Vance; D Schmechel; A M Saunders; D Goldgaber; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  Ultrastructure of diffuse plaques in senile dementia of the Alzheimer type: comparison with primitive plaques.

Authors:  H Yamaguchi; Y Nakazato; M Shoji; M Takatama; S Hirai
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

Authors:  M Shoji; T E Golde; J Ghiso; T T Cheung; S Estus; L M Shaffer; X D Cai; D M McKay; R Tintner; B Frangione
Journal:  Science       Date:  1992-10-02       Impact factor: 47.728

8.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Cerebral beta amyloid deposition in patients with malignant neoplasms: its prevalence with aging and effects of radiation therapy on vascular amyloid.

Authors:  S Sugihara; A Ogawa; Y Nakazato; H Yamaguchi
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

10.  Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state.

Authors:  R A Majack; C K Castle; L V Goodman; K H Weisgraber; R W Mahley; E M Shooter; P J Gebicke-Haerter
Journal:  J Cell Biol       Date:  1988-09       Impact factor: 10.539

View more
  14 in total

1.  Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.

Authors:  M M Verbeek; I Otte-Höller; J van den Born; L P van den Heuvel; G David; P Wesseling; R M de Waal
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations.

Authors:  Roger A Moore; Andrew Timmes; Phillip A Wilmarth; Suzette A Priola
Journal:  Proteomics       Date:  2010-08       Impact factor: 3.984

Review 3.  Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy.

Authors:  Vitaly Vasilevko; Giselle F Passos; Daniel Quiring; Elizabeth Head; Richard C Kim; Mark Fisher; David H Cribbs
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

4.  Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Authors:  D R Premkumar; D L Cohen; P Hedera; R P Friedland; R N Kalaria
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

5.  Analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease using Fourier (spectral) analysis.

Authors:  R A Armstrong; N J Cairns
Journal:  Neuropathol Appl Neurobiol       Date:  2010-01-29       Impact factor: 8.090

6.  Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.

Authors:  Mitsuru Shinohara; Shinsuke Fujioka; Melissa E Murray; Aleksandra Wojtas; Matthew Baker; Anne Rovelet-Lecrux; Rosa Rademakers; Pritam Das; Joseph E Parisi; Neill R Graff-Radford; Ronald C Petersen; Dennis W Dickson; Guojun Bu
Journal:  Brain       Date:  2014-03-12       Impact factor: 13.501

7.  Cerebral beta amyloid deposition in patients with malignant neoplasms: its prevalence with aging and effects of radiation therapy on vascular amyloid.

Authors:  S Sugihara; A Ogawa; Y Nakazato; H Yamaguchi
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Immunohistochemical study of apolipoprotein E in human cerebrovascular white matter lesions.

Authors:  H Tomimoto; I Akiguchi; T Suenaga; H Wakita; S Nakamura; J Kimura; H Budka
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells.

Authors:  Micha M M Wilhelmus; Irene Otte-Höller; Jos J J van Triel; Robert Veerhuis; Marion L C Maat-Schieman; Guojun Bu; Robert M W de Waal; Marcel M Verbeek
Journal:  Am J Pathol       Date:  2007-11-30       Impact factor: 4.307

10.  Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease.

Authors:  Mitsuru Shinohara; Shunsuke Koga; Takuya Konno; Jeremy Nix; Motoko Shinohara; Naoya Aoki; Pritam Das; Joseph E Parisi; Ronald C Petersen; Terrone L Rosenberry; Dennis W Dickson; Guojun Bu
Journal:  Brain       Date:  2017-12-01       Impact factor: 15.255

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.